Helius Medical Technologies, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Polar Asset Management Partners Inc. has disclosed a beneficial ownership of 4.0% in Solana Co's Class A Common Stock, holding 2,305,169 shares.
NASDAQ
Solana Rocket Holdings Limited and CHUNG Wai Shing have filed an amended Schedule 13G reporting a 9.99% beneficial ownership stake in Solana Co.
NASDAQ
Kathmere Capital Management, LLC has reported a passive 8.7% beneficial ownership stake in Solana Co's Class A Common Stock.
NASDAQ
Polar Asset Management Partners Inc. has reported a 5.8% beneficial ownership stake in Solana Co, including shares from warrants.
NASDAQ
Solana Rocket Holdings Limited and its controlling shareholder, CHUNG Wai Shing, have disclosed a 9.99% beneficial ownership stake in Solana Co, capped by a beneficial ownership blocker.
NASDAQ
Solana Rocket Holdings Limited and its controlling shareholder, CHUNG Wai Shing, reported a 9.99% beneficial ownership stake in Helius Medical Technologies, Inc.
NASDAQ
Armistice Capital and Steven Boyd reported a 4.99% beneficial ownership stake in Helius Medical Technologies, Inc. Class A Common Stock.
NASDAQ
L1 Capital Global Opportunities Master Fund, Ltd. has filed an amended Schedule 13G, disclosing a 1.01% beneficial ownership stake in Helius Medical Technologies, Inc.
NASDAQ
CVI Investments, Inc. and Heights Capital Management, Inc. have reported zero beneficial ownership in Helius Medical Technologies, Inc. Class A Common Stock.
NASDAQ
SCHEDULE 13G: L1 Capital Global Opportunities Master Fund Discloses 6.78% Stake in Helius Medical Technologies
L1 Capital Global Opportunities Master Fund, Ltd. has reported a 6.78% beneficial ownership stake in Helius Medical Technologies, Inc., as detailed in a recent Schedule 13G filing.
NASDAQ
SCHEDULE 13G: CVI Investments and Heights Capital Management Disclose 5.8% Stake in Helius Medical Technologies
CVI Investments, Inc. and its investment manager, Heights Capital Management, Inc., have jointly disclosed a beneficial ownership of 5.8% in Helius Medical Technologies, Inc., totaling 183,450 shares of Class A Common Stock.
NASDAQ
SCHEDULE 13G: Leonite Fund I and Avi Geller Disclose 5.19% Passive Stake in Helius Medical Technologies
Leonite Fund I, LP and Avi Geller have jointly filed a Schedule 13G, disclosing a beneficial ownership of 5.19% of Helius Medical Technologies, Inc.'s common shares.
NASDAQ
SCHEDULE 13G: FirstFire Global Opportunities Fund Discloses 5.73% Stake in Helius Medical Technologies
FirstFire Global Opportunities Fund LLC has reported a 5.73% beneficial ownership stake in Helius Medical Technologies, Inc., as disclosed in a recent Schedule 13G filing.
NASDAQ
Investment firm Armistice Capital, LLC and its managing member Steven Boyd have disclosed a beneficial ownership of 9.99% in Helius Medical Technologies, Inc.'s Class A Common Stock.